Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

H5N1 virus mutating in humans, study finds
The human strain of H5N1 caused a more severe disease than the bovine strain.
Research found nine additional mutations in the human strain.

A study into the spread of H5N1 in the United States of America has revealed that the virus has developed new mutations in human hosts.

Researchers from Texas Biomedical Research Institute (Texas Biomed) identified nine additional mutations in the human strain of H5N1 compared to the strain present in bovines.

H5N1, commonly known as bird flu, is naturally found in wild birds and is lethal in chickens. It has since spread through a variety of mammals, first being identified in dairy cows in spring 2024.

The first reported death caused by H5N1 was reported in January 2025, as a result of exposure to infected chickens.

Researchers are increasingly concerned about the evolution of the virus, particularly of its potential to transmit from human to human. Texas Biomed has been studying H5N1 since the outbreak began last year, using specialised tools and animal models.

When comparing the human strain of H5N1 to the strain in bovines, researchers identified nine additional mutations which were believed to have occurred after human infection.

The study found that the human strain of H5N1 caused a more severe disease than the bovine strain. The human strain also replicated more efficiently and was found in much higher quantities in brain tissue.

However, the researchers did also identify that the mutations were not affecting the efficacy of approved antibiotics.

The researchers say that this is an important finding, as antibiotics will be vital if a pandemic does occur. Humans have no pre-existing immunity against H5N1, and seasonal flu vaccines offer limited protection.

Future research will see the team explore the human strain individually, investigating why infections from cows appear to be less harmful than from chickens. They will also examine why H5N1 causes mild disease in cows, but is lethal in cats.

Ahmed Mostafa Elsayed, staff scientist at Texas Biomed, said: "A key priority will be to eradicate bird flu from dairy cows to minimize risk of mutations and transmission to people and other species,

"Steps that can be taken now include thorough decontamination of milking equipment and more stringent quarantine requirements, which will help eliminate the virus more quickly in cows."

The full study can be found in the journal Emerging Microbes and Infections.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.